ヒト肝臓モデルの世界市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

ヒト肝臓モデルの市場規模と動向：

世界のヒト肝臓モデルの市場規模は、2024年に13億4,000万米ドルとなり、2025年から2030年にかけてCAGR 14.04%で成長すると予測されています。

この業界では、肝臓疾患の有病率の増加、臓器プリンティング技術の進歩、肝臓がんの治療薬需要の増加などが成長の原動力となっています。

保健資源・サービス庁によると、米国では2023年、10万6800人が臓器移植を待っています。医療の状況は進化しており、3Dプリンティング技術の進歩は、臓器不足に対処し、世界的に患者ケアを改善することで、医療を変革しようとしています。

肝臓疾患の有病率は世界的に上昇傾向にあり、ヒト肝臓モデルなどの高度な調査ツールに対する需要が高まっています。非アルコール性脂肪性肝疾患 (NAFLD)、アルコール性肝疾患、ウイルス性肝炎、肝がんなどの慢性肝疾患は、不健康な食生活、座りがちなライフスタイル、アルコール摂取、ウイルス感染などの要因により、ますます一般的になりつつあります。例えば、NAFLDは欧米諸国で最も流行している慢性肝疾患であり、世界人口の約25%が罹患しています。このような肝疾患の有病率の大幅な上昇により、研究や医薬品開発を支援するため、より正確で効率的なヒト肝臓モデルの緊急ニーズが高まっています。

臓器3Dプリンティング技術は、特にヒト肝臓モデルの開発において、最近の著しい進歩を遂げています。こうした進歩は、研究目的により正確で個別化されたモデルを提供することで、再生医療と薬剤試験に革命をもたらしています。例えば、2023年2月、カリフォルニア大学サンディエゴ校の研究者たちは、3D造形組織のバイオプリントにおける課題への取り組みにおいて大きな進歩を遂げ、高い細胞密度、生存率、正確な造形解像度を達成しました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 ヒト肝臓モデル市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• ヒト肝臓モデル市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 ヒト肝臓モデル市場：製品別の推定・動向分析

• 製品別のダッシュボード
• ヒト肝臓モデル市場：製品別の変動分析
• ヒト肝臓モデル市場：市場規模の予測と動向分析、製品別 (2018～2030年)
• 2Dモデル
  • 細胞株
  • 一次細胞
• 3Dモデル
  • レバーオンチップ
  • オルガノイド
  • 球状体
  • その他

第5章 ヒト肝臓モデル市場：用途別の推定・動向分析

• 用途別のダッシュボード
• ヒト肝臓モデル市場：用途別の変動分析
• ヒト肝臓モデル市場：市場規模の予測と動向分析、用途別 (2018～2030年)
• ADME研究
• 毒性試験
• 疾患モデル化
• その他

第6章 ヒト肝臓モデル市場：最終用途別の推定・動向分析

• 最終用途別のダッシュボード
• ヒト肝臓モデル市場：最終用途別の変動分析
• ヒト肝臓モデル市場：市場規模の予測と動向分析、最終用途別 (2018～2030年)
• 学術研究機関
• 製薬・バイオ製品企業
• CRO

第7章 ヒト肝臓モデル市場：地域別の推定・動向分析

• ヒト肝臓モデル市場：地域別の推定・動向分析、製品別・用途別・最終用途別
• 市場ダッシュボード：地域別
• 市場シェア：地域別 (2024年・2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析 (2024年)
• 企業プロファイル
  • ATCC
  • Merck KGaA
  • AcceGen
  • ZenBio, Inc.
  • Organovo Holdings Inc.
  • BioIVT
  • InSphero
  • Emulate, Inc.
  • Mimetas
  • CN Bio Innovations Ltd

List of Tables

• Table 1 List of abbreviation
• Table 2 Global human liver models market, by region, 2018 - 2030 (USD Million)
• Table 3 Global human liver models market, by product, 2018 - 2030 (USD Million)
• Table 4 Global human liver models market, by application, 2018 - 2030 (USD Million)
• Table 5 Global human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 6 North America human liver models market, by country, 2018 - 2030 (USD Million)
• Table 7 North America human liver models market, by product, 2018 - 2030 (USD Million)
• Table 8 North America human liver models market, by application, 2018 - 2030 (USD Million)
• Table 9 North America human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 10 U.S. human liver models market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. human liver models market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 13 Canada human liver models market, by product, 2018 - 2030 (USD Million)
• Table 14 Canada human liver models market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Mexico human liver models market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico human liver models market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Europe human liver models market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe human liver models market, by product, 2018 - 2030 (USD Million)
• Table 21 Europe human liver models market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 23 Germany human liver models market, by product, 2018 - 2030 (USD Million)
• Table 24 Germany human liver models market, by application, 2018 - 2030 (USD Million)
• Table 25 Germany human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 26 UK human liver models market, by product, 2018 - 2030 (USD Million)
• Table 27 UK human liver models market, by application, 2018 - 2030 (USD Million)
• Table 28 UK human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 29 France human liver models market, by product, 2018 - 2030 (USD Million)
• Table 30 France human liver models market, by application, 2018 - 2030 (USD Million)
• Table 31 France human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 32 Italy human liver models market, by product, 2018 - 2030 (USD Million)
• Table 33 Italy human liver models market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 35 Spain human liver models market, by product, 2018 - 2030 (USD Million)
• Table 36 Spain human liver models market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Denmark human liver models market, by product, 2018 - 2030 (USD Million)
• Table 39 Denmark human liver models market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Sweden human liver models market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden human liver models market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Norway human liver models market, by product, 2018 - 2030 (USD Million)
• Table 45 Norway human liver models market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific human liver models market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific human liver models market, by product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific human liver models market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 51 China human liver models market, by product, 2018 - 2030 (USD Million)
• Table 52 China human liver models market, by application, 2018 - 2030 (USD Million)
• Table 53 China human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Japan human liver models market, by product, 2018 - 2030 (USD Million)
• Table 55 Japan human liver models market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 57 India human liver models market, by product, 2018 - 2030 (USD Million)
• Table 58 India human liver models market, by application, 2018 - 2030 (USD Million)
• Table 59 India human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 60 South Korea human liver models market, by product, 2018 - 2030 (USD Million)
• Table 61 South Korea human liver models market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Australia human liver models market, by product, 2018 - 2030 (USD Million)
• Table 64 Australia human liver models market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Thailand human liver models market, by product, 2018 - 2030 (USD Million)
• Table 67 Thailand human liver models market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Latin America human liver models market, by product, 2018 - 2030 (USD Million)
• Table 70 Latin America human liver models market, by application, 2018 - 2030 (USD Million)
• Table 71 Latin America human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Brazil human liver models market, by product, 2018 - 2030 (USD Million)
• Table 73 Brazil human liver models market, by application, 2018 - 2030 (USD Million)
• Table 74 Brazil human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Argentina human liver models market, by product, 2018 - 2030 (USD Million)
• Table 76 Argentina human liver models market, by application, 2018 - 2030 (USD Million)
• Table 77 Argentina human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 78 MEA human liver models market, by region, 2018 - 2030 (USD Million)
• Table 79 MEA human liver models market, by product, 2018 - 2030 (USD Million)
• Table 80 MEA human liver models market, by application, 2018 - 2030 (USD Million)
• Table 81 MEA human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 82 South Africa human liver models market, by product, 2018 - 2030 (USD Million)
• Table 83 South Africa human liver models market, by application, 2018 - 2030 (USD Million)
• Table 84 South Africa human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia human liver models market, by product, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia human liver models market, by application, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 88 UAE human liver models market, by product, 2018 - 2030 (USD Million)
• Table 89 UAE human liver models market, by application, 2018 - 2030 (USD Million)
• Table 90 UAE human liver models market, by end-use, 2018 - 2030 (USD Million)
• Table 91 Kuwait human liver models market, by product, 2018 - 2030 (USD Million)
• Table 92 Kuwait human liver models market, by application, 2018 - 2030 (USD Million)
• Table 93 Kuwait human liver models market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Parent market outlook
• Fig. 9 Related/ancillary market outlook
• Fig. 10 Human liver models market driver impact
• Fig. 11 Human liver models market restraint impact
• Fig. 12 Human liver models market: Product movement analysis
• Fig. 13 Human liver models market: Product outlook and key takeaways
• Fig. 14 2D models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Cell lines market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Primary cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 3D models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Liver on chip market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Organoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Spheroids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Human liver models market: Application movement analysis
• Fig. 23 Human liver models market: Application outlook and key takeaways
• Fig. 24 ADME studies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Disease modelling market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Human liver models market: End-use movement analysis
• Fig. 29 Human liver models market: End-use outlook and key takeaways
• Fig. 30 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Pharmaceutical & bioproduct companies market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 32 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Global human liver models market: Regional movement analysis
• Fig. 34 Global human liver models market: Regional outlook and key takeaways
• Fig. 35 Global human liver models market share and leading players
• Fig. 36 North America
• Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. key country dynamics
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Canada key country dynamics
• Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Mexico key country dynamics
• Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Europe
• Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 UK key country dynamics
• Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Germany key country dynamics
• Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 France key country dynamics
• Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Italy key country dynamics
• Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Spain key country dynamics
• Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Denmark key country dynamics
• Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Sweden key country dynamics
• Fig. 59 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Norway key country dynamics
• Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Asia Pacific
• Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 China key country dynamics
• Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Japan key country dynamics
• Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 India key country dynamics
• Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Australia key country dynamics
• Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 South Korea key country dynamics
• Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Thailand key country dynamics
• Fig. 75 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Latin America
• Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Brazil key country dynamics
• Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Argentina key country dynamics
• Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Middle East and Africa
• Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 South Africa key country dynamics
• Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Saudi Arabia key country dynamics
• Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 UAE key country dynamics
• Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Kuwait key country dynamics
• Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Human Liver Model Market Size & Trends:

The global human liver model market size was valued at USD 1.34 billion in 2024 and is projected to grow at a CAGR of 14.04% from 2025 to 2030. The industry is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected to propel its growth.

According to the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set to transform healthcare by addressing organ shortages and improving patient care globally.

The prevalence of liver diseases is on the rise globally, leading to a growing demand for advanced research tools, including human liver models. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due to factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient human liver models to support research and drug development efforts.

Organ 3D printing technologies have advanced significantly recently, particularly in developing human liver models. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Diego made significant progress in addressing challenging issues in bio-printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.

Global Human Liver Model Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global human liver model market report on the basis of product, application, end-use, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• 2D Models
  • Cell lines
  • Primary Cells
• 3D Models
  • Liver on Chip
  • Organoids
  • Spheroids
  • Others
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• ADME Studies
• Toxicology Testing
• Disease Modelling
• Others
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Human Liver Model Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of liver diseases
    • 3.2.1.2. Advancements in organ printing technologies
    • 3.2.1.3. Increased demand for therapeutic drugs for liver cancer
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High costs and complexity associated with maintaining human liver models
• 3.3. Human Liver Model Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Liver Model Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Human Liver Model Market Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. 2D Models
  • 4.4.1. 2D models market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Cell Lines
    • 4.4.2.1. Cell Lines market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Primary Cells
    • 4.4.3.1. Primary Cells market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. 3D Models
  • 4.5.1. 3D models market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Liver on Chip
    • 4.5.2.1. Liver on Chip market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Organoids
    • 4.5.3.1. Organoids market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Spheroids
    • 4.5.4.1. Spheroids market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Liver Model Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Human Liver Model Market Application Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. ADME Studies
  • 5.4.1. ADME Studies market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Toxicology Testing
  • 5.5.1. Toxicology Testing market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Disease Modelling
  • 5.6.1. Disease Modelling market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Liver Model Market: End-use Estimates & Trend Analysis

• 6.1. End-use Segment Dashboard
• 6.2. Global Human Liver Model Market End-use Movement Analysis, 2024 & 2030 (USD Million)
• 6.3. Global Human Liver Model Market Size and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Academic & Research Institutes
  • 6.4.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Pharmaceutical & Bioproduct Companies
  • 6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Contract Research Organizations
  • 6.6.1. Contract Research Organizations market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Liver Model Market: Regional Estimates & Trend Analysis

• 7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End-use
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Share Analysis, 2024 & 2030
• 7.4. North America
  • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Competitive scenario
    • 7.5.9.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. ATCC
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. AcceGen
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. ZenBio, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Organovo Holdings Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. BioIVT
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. InSphero
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Emulate, Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Mimetas
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. CN Bio Innovations Ltd
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives